Quest Diagnostics Reports Second Quarter 2020 Financial Results

Go back to Quest Diagnostics Reports Second Quarter 2020 Financial Results

Quest Diagnostics (DGX) PT Raised to $148 at BofA Securities

July 24, 2020 8:16 AM EDT

BofA Securities analyst Derik de Bruin raised the price target on Quest Diagnostics (NYSE: DGX) to $148.00 (from $142.00) while maintaining a Buy rating.

... More

Quest Diagnostics (DGX) Tops Q2 EPS by 2c; Reiterates FY Outlook

July 23, 2020 6:46 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.42, $0.02 better than the analyst estimate of $1.40. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.83 billion.

"In one of the most challenging periods in our history, Quest Diagnostics stepped up and... More